Put two packs of CBD seeds next to each other, one labelled 1:1 and the other 20:1, and they look the same: the same breeder’s packaging, same seed count, contents which no eye can separate apart. Run them in the same tent and they part ways at the first step and do not meet again. The cause is a single gene, and the easiest way to understand what it does is to follow the two packs along every step they share: the breeding that produced them, the seed, the seedling, the flowering room, the harvest, the jar, the lab report and the border. The lines used as reference points below are drawn from the range at https://calmcbdseeds.com, which goes 1:1, 2:1 and 20:1 with a highest line at about 30 to one; the genetics is the same regardless of which shop the seeds came from.
Stage One: At the Breeder’s Bench
Cannabis settles whether it will make THC or CBD at one locus on the genome. The gene there exists in two versions: one codes the enzyme that converts the common starting molecule into THCA, the other the enzyme that turns it into CBDA. Each plant carries two copies, one inherited from each parent, and the pair sets the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies make a CBD-dominant one. One of each makes a balanced plant, since the two forms are codominant and not one of them silences the other.
The balanced pack was made by pairing two balanced plants, each carrying one copy of each form. The CBD-dominant pack was bred by pairing two plants that both hold two CBD copies and not a single THC copy in either of them. This one difference at the cross decides everything afterwards, and it is fully inside the seed long before it is packed.
What the Pack Actually Holds
Cross two balanced plants and the offspring sort themselves by the simplest arithmetic in genetics: a quarter get two THC copies, a quarter inherit two CBD copies, half inherit one of each. In a pack of 10 seeds that works out to, on average, two or three THC-dominant seeds, two or three CBD-dominant seeds, and about five true balanced seeds. The pack is sold by its parents, and in the case of half its contents the label is accurate; for the other half it is a description of something else. Calm CBD Seeds states the expected split on every balanced pack, which means the buyer sees ahead of sowing that a portion of the plants will depart from the headline ratio.
The CBD-dominant pack carries no such spread. Every seed received a CBD copy from both parent, each plant is going to be CBD-dominant, and the ratio on the foil applies to all of them, give or take the ordinary differences in how much total cannabinoid any given plant builds. Breeders say such lines “breed true” for chemotype; the phrase refers to precisely this lack of surprise.
Where Nothing Shows
At this stage the two packs look alike again, and the resemblance lasts further than many growers expect. Chemotype shows no mark on a seedling. Leaf shape, colour, internode length and growth rate are governed by other genes altogether, and the different chemotypes of plant in the balanced pack come up indistinguishably beside one another and from every plant in the CBD-dominant pack.
One practical distinction during this stage comes from ancestry not chemotype. Lines with recent hemp ancestry, which includes some older CBD-dominant lines, tend to grow taller and branch more sparsely. A well-worked 20:1 line behaves like any modern hybrid; a young one may still shows the field in its frame. Not one of these tendency tells a thing about the ratio to come.
Frost, Smell and the Wrong Conclusions
In flower the two packs start to offer clues, and most of the clues mislead. Trichome coverage is the usual thing a grower reads, and it was a reasonable rule: early CBD-dominant lines showed markedly less frost than their THC counterparts, an unwanted legacy from hemp. Current selections have mostly closed that gap, and a lightly frosted plant from the CBD-dominant pack can perfectly well test exactly where the foil promised. Trichome density and chemotype are carried on separate genes.
Smell is an even poorer guide. The terpene chemistry sits on yet different genes, so the THC-dominant plant sitting in the balanced pack can be identical to the balanced one next to it, and either can be indistinguishable to a plant from the CBD-dominant pack. People who attempt to separate a balanced pack by nose in week eight are guessing, and that is not any better than leaving the plants sorting at all.
One Place CBD Is More Forgiving
Here the two packs differ in a way that favours the grower of the CBD-dominant pack and the CBD-dominant plants sitting in the balanced pack. CBDA breaks down rather gradually than THCA, so a CBD-dominant plant left a week beyond its ideal point retains the bulk of its cannabinoid content, where a THC-dominant one in the same conditions has by then begun shedding THC to CBN. The cloudy guidance nonetheless holds; it applies on account of the terpenes, which fade on every plant regardless the chemotype, and a late, over-dried CBD flower smells of little however good the lab result is.
Stage Six: The Jar
The CBD-dominant pack can go into one jar. Every plant in it holds roughly the same ratio, and blending them changes nothing worth notice. The balanced pack cannot be treated that way. Blend its 10 plants into a single jar and the result become a mixture that no foil ever promised, weighted by whichever plants yielded most, and nothing on a subsequent test can untangle what went in.
The habit that prevents the grief is almost tedious: cut the balanced pack plant by plant, cure every one separately, label them, and test each one plant at a time rather than after the crop is mixed. It is the one point in the whole grow where the different chemotypes of plant in the balanced pack can yet be told apart short of a lab, and only for the reason that every one is at that moment in its own container.
Stage Seven: The Lab Report
Send a sample from every jar to a laboratory and the two packs at last become legible. For the CBD-dominant pack the certificates arrive back grouped tightly around the stated ratio, differing mostly in total cannabinoid content not in balance. For the balanced pack they arrive back in three clusters: some reports with almost all THC, a few showing nearly all CBD, and the majority somewhere near one to one. No part of this result is a defect; it is the breeder’s cross written out as numbers.
Over-the-counter test kits exist for growers without a laboratory, and the majority of them detect whether THC is present rather than how much. That is enough to separate the THC-dominant jars out of a balanced pack and not to assign a ratio to the others, and that matches the commonest need: finding out what of the ten jars will surprise a guest.
Hemp Threshold Versus Chemotype
The last stage at which the two packs separate is legal, and it trips growers who thought “CBD” was shorthand for “hemp”. Most countries classify hemp by a THC limit, a small fraction of a percent of dry weight, and the exact number differing from country and sometimes year to year. A plant from the CBD-dominant pack producing twenty percent CBD at twenty to one also makes about one percent THC, and that is several times above most limits. Compliant lines are selected to hold total cannabinoid content down so the THC fraction stays under the line at harvest; CBD flower lines are bred for high output and let the THC rise with it. A shop that offers only a ratio is selling a flower line; anyone who requires a compliant crop needs to ask for a tested THC percentage at harvest and buy nothing that does not show one.
Beyond the threshold issue, the chemotype alters very little about the law on the seed itself. Where owning cannabis seeds is lawful and germinating them is not, the balanced pack and the CBD-dominant pack sit in the same position as every other pack. In places where the plant is legal without restriction, the choice between them is a matter of preference and nobody else’s. No part of this page is legal advice, and the law which applies is the one in the place the seed is going to be grown, not the one where it was bought.